Sorrento Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2022.
  • Sorrento Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $61.2M, a 64.7% decline year-over-year.
  • Sorrento Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $312M, a 71.9% increase from 2021.
  • Sorrento Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $181M, a 4.07% increase from 2020.
  • Sorrento Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $174M, a 121% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $312M +$130M +71.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $181M +$7.09M +4.07% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $174M +$95.4M +121% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $78.9M -$247M -75.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $326M +$272M +507% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $53.7M -$78.1M -59.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $132M +$135M Jan 1, 2016 Dec 31, 2016 8-K 2019-06-17
2015 -$3.35M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2013 $43.6M +$37.6M +630% Jan 1, 2013 Dec 31, 2013 10-K 2014-04-01
2012 $5.97M +$3.99M +201% Jan 1, 2012 Dec 31, 2012 10-K 2014-04-01
2011 $1.98M -$1.46M -42.3% Jan 1, 2011 Dec 31, 2011 10-K/A 2013-03-27
2010 $3.44M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.